The UK Kidney Asscciation
@UKKidney
から高K血症guidelineのupdate。新規K吸着薬をおりこんだ改訂。腎臓内科として感じますが高Kに対するロケルマの威力は絶大ですね。緊急透析の機会がこれだけでだいぶ減った気がします。腸管から入れてるのに即効性があるのも不思議ですよね。
🚨 Updated guidelines alert! The UKKA’s latest update on Treatment of Acute Hyperkalaemia in Adults brings crucial changes. From IV calcium salt rates to novel potassium binder use for moderate & severe cases, these changes are reshaping care standards.
➡️
AHAから急性期の高血圧マネジメント
The Management of Elevated Blood Pressure in the Acute Care Setting: A Scientific Statement From the American Heart Association
@AHAScience
Hypertensive Urgency高血圧切迫症からAssymptomatic markedly elevated BPにtermが変更
血液透析患者の管理は保存期CKDのポイントからマイナーチェンジを加えたABCDEの10ポイントで考えるといいと指導してます。
A ①Access②Anemia
B ③Blood pressure
C ④CKD-MBD/⑤Cholesterol
D ⑥Dry Weight/⑦Diets/⑧DM
E ⑨Electrolytes/⑩efficacy
早期2型DMに対するSGLT2i vs メトホルミンという以前議論にあがったCQをみるstudy
A registry-based randomised trial comparing an SGLT2 inhibitor and metformin as standard treatment of early stage type 2 diabetes (SMARTEST): Rationale, design and protocol
This study provides Class II evidence that among those aged 65 years or older, statin initiation was associated with a reduced risk of
#Alzheimer
disease, especially in the presence of an APOE-e4 allele:
RAS阻害薬中止後の再開は腎予後と生命予後を改善するが高K血症を増やさないことを示したtarget trial emulation study
@JASN_News
(2024)
Estimated Effect of Restarting Renin-Angiotensin System Inhibitors after Discontinuation on Kidney Outcomes and Mortality
KDIGO is pleased to announce the publication of the 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (CKD).
Read the news release:
Download the guideline:
Read the guideline in Kidney
ロケルマ®︎の短期的な医療コストへの影響をみたstudy。3ヶ月で総医療費は使用群で43%低下。
@AdvancesTherapy
(2023)
Impact of Sodium Zirconium Cyclosilicate Plus Renin–Angiotensin–Aldosterone System Inhibitor Therapy on Short-Term Medical Costs in Hyperkalemia
痛風とCKD患者のマネジメントに関するmini review
@Kidney_Int
(2024)
無症候でも食事や薬剤調整など後もUA>9 mg/dlの場合は薬物治療考慮のアルゴリズムになっているのが驚きですね
Controversies and practical management of patients with gout and chronic kidney disease